Publications & Reports

2024

“Shared experience makes this all possible”: documenting the guiding principles of peer-led services for people released from prison. (Palis H, et al.)
2024 | BMC Public Health | Available online: here

2023

Test Link Call Project Impact Evaluation Report 2021-2022. (Gale, N., Tiwana, A., & Bartlett, S.R).
2023 | BC Centre for Disease Control  | Available online: here

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study (Hamill V, et al.)
2023 | British Medical Journal | Available online: here

Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada (Reddon H, et al.)
2023 | Scientific Reports | Available online: here

Expanding access to hepatitis C prevention, testing, and treatment in prisons: Recommendations from the INHSU 2022 Prisons Workshop. (Coalition for Global Hepatitis Elimination and INHSU Prisons)
2023 | The Task Force for Global Health | Available online: here

Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study (Snell G, et al.)
2023 | Canadian Liver Journal  | Available online: here

Progress Towards Viral Hepatitis Elimination In Canada 2023 Report (Action Hepatitis Canada)
2023 | Action Hepatitis Canada  | Available online: here

2022

Prison Health Is Public Health: The Right to Hepatitis C Prevention, Diagnosis, and Care in Canada’s Correctional Settings (Action Hepatitis Canada)
2022 | Action Hepatitis Canada  | Available online

Sexually transmitted and blood-borne infection testing and linkage to care during incarceration: There’s no time like the prison time! (Bartlett et al.)
2022 | University of British Columbia Medical Journal | Available online

2021

It is Time for Us All to Embrace Person-Centred Language for People in Prison and People Who were Formerly in Prison (Harney et al.)
2021 | International Journal of Drug Policy | Available online | Lay Summary

Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct-Acting Antiviral Era (Bartlett et al.)
2021 | Clinical Liver Disease | Available online

The Impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from the direct-acting antiviral (DAA) era: A population-based study (Bartlett et al.)
2021 | Clinical Infectious Diseases | Available online

“They look at you like you’re contaminated”: how HIV-related stigma shapes access to care for incarcerated women living with HIV in a Canadian setting (Erickson et al.)
2021 | Canadian Journal of Public Health | Abstract

“The Times They Are a-Changin’”: Addressing Common Misconceptions About the Role of Safe Supply in North America’s Overdose Crisis (Bonn et al.)
2021 | Journal of Studies on Alcohol and Drugs | Available online

Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination (Kronfli et al.)
2021 | Canadian Liver Journal | Available online

2020

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply (Bonn et al.)
2020 | Journal of studies on alcohol and drugs | Available online

Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada (Samji et al.)
2020 | International Journal of Drug Policy | Available online

2019

The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals (Bartlett et al.)
2019 | Liver International | Available online

2018

Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project (Bartlett et al.)
2018 | Clinical Infectious Diseases | Available online